Perspective Therapeutics (CATX) Shares Outstanding (Diluted) (2023 - 2026)
Perspective Therapeutics (CATX) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 386.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 577.60 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 390.10 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 454.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 968.57 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 97.90 Mn |
| 10 | Perspective Therapeutics | 387.29 Mn | 387.29 Mn | - | 120.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120.65 Mn |
| Mar 31, 2026 | 103.60 Mn |
| Dec 31, 2025 | 73.81 Mn |
| Sep 30, 2025 | 74.30 Mn |
| Jun 30, 2025 | 74.24 Mn |
| Mar 31, 2025 | 72.36 Mn |
| Dec 31, 2024 | 64.43 Mn |
| Sep 30, 2024 | 70.63 Mn |
| Jun 30, 2024 | 66.65 Mn |
| Mar 31, 2024 | 49.51 Mn |
| Dec 31, 2023 | 26.76 Mn |
| Sep 30, 2023 | 28.06 Mn |
| Jun 30, 2023 | 28.00 Mn |
| Mar 31, 2023 | 22.86 Mn |